文献速递颈动脉与弓上血管

部分外翻式颈动脉内膜切除术17年525例连续病例结局

Partial Eversion Carotid Endarterectomy: 17-Year Outcomes in 525 Consecutive Patients Support Safety and Reproducibility beyond the Learning Curve.
PubMed 文献 · Ann Vasc Surg · 2026-09-04

结果显示30天卒中率1.3%、死亡率0.4%,两时间段结局稳定,提示该术式安全、可重复。

要点

  • 30天卒中/死亡合并率为1.3%(7/525;95%CI 0.54-2.73)。
  • 有症状患者30天卒中/死亡率为1.41%(6/425;95%CI 0.52-3.05)。
  • 无颅神经损伤记录,中位颈内动脉阻断时间14分钟。

核心结论

  • PECE是安全、可重复且技术上高效的颈动脉内膜切除术式,17年525例连续病例的30天结局持续达到国际公认阈值。
  • 本系列主要贡献在于证明该技术在成熟期再8年临床实践中维持了良好结局,新增173例使总队列增加近50%。

研究设计与样本

  • 全部手术由单一顾问血管外科医生完成,PECE作为默认术式、未做解剖学预先筛选,共525例。
  • 按时间分为原始队列(2006-2015年,n=352)和扩展队列(2016-2023年,n=173)。
  • 连续变量采用Mann-Whitney U检验,分类结局采用Fisher精确检验,P<0.05为显著。
  • 17年指连续实践取样跨度,而非个体患者随访时长;所有终点均为围手术期或早期术后。

主要发现

  • 中位年龄70岁(范围44-96岁),男性占60.6%,99.2%采用局部麻醉。
  • 中位颈内动脉阻断时间14分钟(IQR 11.5-17分钟),中位手术时间41分钟(原始队列IQR 36-43分钟),两队列间稳定(P=0.81和P=0.72)。
  • 30天卒中率1.3%(n=7;95%CI 0.54-2.73),死亡率0.4%(n=2;95%CI 0.05-1.37),2例死亡均发生于围手术期卒中患者。
  • 以发生卒中或死亡的患者数计,30天卒中/死亡合并率为1.3%(n=7;95%CI 0.54-2.73)。
  • 围手术期短暂性脑缺血发作1.0%(n=5),均在出院前缓解;无显著颅神经损伤记录。

关键数值与推荐

  • 有症状患者30天卒中/死亡率为1.41%(6/425;95%CI 0.52-3.05)。
  • 无症状患者30天卒中/死亡率为1.64%(1/61;95%CI 0.04-8.80)。
  • 心脏手术前接受内膜切除术者30天卒中/死亡率为0%(0/39;95%CI 0.00-9.03)。
  • 原始队列185例按方案行纵向双功超声监测至24个月,未发现≥50%再狭窄。
  • 其余两队列患者仅在术后4-6周行单次双功超声,未显示早期技术异常,但该检查不能排除后续再狭窄。

临床怎么用

  • PECE可作为颈动脉内膜切除术的默认术式,无需解剖学预先筛选,适用于有症状及无症状的合适患者。
  • 局部麻醉下操作,中位颈内动脉阻断14分钟、手术时间41分钟,技术效率较高。
  • 围手术期结局达到国际公认阈值,可用于向患者说明30天卒中/死亡风险。
  • 术后早期双功超声可评估技术结果,但长期再狭窄监测方案尚需确立。

局限性

  • 回顾性单中心、单一术者经验,结果外推性受限。
  • 17年为连续实践取样跨度,非个体患者随访时长,所有终点为围手术期或早期术后。
  • 未开展延长的逐患者监测,技术超越围手术期的持久性尚待确立。
  • 多数患者仅有术后4-6周单次双功超声,不能排除后续再狭窄。
  • 作者建议开展前瞻性多中心及随机研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Carotid endarterectomy (CEA) is the established surgical intervention for stroke risk reduction in patients with significant carotid artery stenosis. Partial eversion carotid endarterectomy (PECE) is a modified operative technique using an oblique anterior wall arteriotomy at the carotid bifurcation, preserving the posterior arterial wall and allowing efficient plaque removal without patch closure. This study presents the largest single-center series of PECE, extending our original 2017 report with a further 8 years of surgical practice. The 17-year period refers to the span of consecutive practice sampled rather than the duration of follow-up of individual patients; all end points are perioperative or early postoperative. The objective was to determine whether the favorable outcomes observed during the developmental phase of the technique were maintained across a subsequent era of mature practice. METHODS: Retrospective analysis of a prospectively maintained clinical database of all consecutive patients undergoing PECE at a single regional vascular center in the United Kingdom between October 2006 and February 2023. All procedures were performed by a single consultant vascular surgeon, for whom PECE was the default technique applied without anatomical preselection to all patients judged to benefit from endarterectomy. Two chronological cohorts were defined: original (2006-2015, n = 352) and extended (2016-2023, n = 173). Demographic data, operative details, 30-day neurologic outcomes, cranial nerve injuries, and duplex-confirmed restenosis rates were recorded. Between-cohort comparisons used the Mann-Whitney U test for continuous variables and Fisher exact test for categorical outcomes; P < 0.05 was considered significant. Thirty-day outcomes were additionally stratified by indication, and exact 95% confidence intervals (CIs) were calculated for all event rates. RESULTS: A total of 525 patients underwent PECE over 17 years. The median age was 70 years (range, 44-96 years); 60.6% were male. Local anesthesia was used in 99.2% of cases. Median internal carotid artery (ICA) clamping time was 14 minutes (interquartile range [IQR], 11.5-17 minutes) and median operative time was 41 minutes (IQR, 36-43 minutes in the original cohort), remaining stable across both cohorts (P = 0.81 and P = 0.72, respectively). The combined 30-day stroke rate was 1.3% (n = 7; 95% CI, 0.54-2.73) and mortality 0.4% (n = 2; 95% CI, 0.05-1.37). Both deaths occurred in patients who had sustained a perioperative stroke; expressed as the number of patients experiencing either outcome, the combined 30-day stroke/death rate was 1.3% (n = 7; 95% CI, 0.54-2.73). Stratified by indication, the 30-day stroke/death rate was 1.41% (6/425; 95% CI, 0.52-3.05) in symptomatic patients, 1.64% (1/61; 95% CI, 0.04-8.80) in asymptomatic patients, and 0% (0/39; 95% CI, 0.00-9.03) in patients undergoing endarterectomy before cardiac surgery. Perioperative transient ischemic attack occurred in 1.0% (n = 5), all resolving before discharge. No significant cranial nerve injuries were recorded. No restenosis of 50% or greater was identified during longitudinal duplex surveillance to 24 months in the 185 patients of the original cohort subject to that protocol; among the remaining patients of either cohort, a single duplex scan at 4 to 6 weeks demonstrated no early technical abnormality, a study that cannot exclude subsequent restenosis. Outcomes remained stable across both chronological periods (P > 0.05 for all end points). CONCLUSION: PECE is a safe, reproducible, and technically efficient technique for CEA with 30-day outcomes consistently meeting internationally accepted thresholds across 17 years and 525 consecutive procedures. The principal contribution of this updated series is the demonstration that favorable outcomes were maintained over a further 8 years of clinical practice, with the addition of 173 cases increasing the total cohort by almost 50%. Extended per-patient surveillance was not undertaken, and the durability of the technique beyond the perioperative period therefore remains to be established. PECE warrants evaluation in prospective multicenter and randomized studies.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Elmetwally A, Meselhi A, Karamitsou A, et al. Partial Eversion Carotid Endarterectomy: 17-Year Outcomes in 525 Consecutive Patients Support Safety and Reproducibility beyond the Learning Curve. Ann Vasc Surg. 2026. PMID: 42697318. doi:10.1016/j.avsg.2026.08.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。